← Back to headlines
U.S. Life Sciences Market Moves Toward Rebalancing as Development Slows
A new commercial real estate report indicates the U.S. life sciences sector is entering a rebalancing phase as capital flows normalize and new development activity slows.
31 Aug, 21:25 — 31 Aug, 21:25
